Quantinuum Files S‑1 for Nasdaq IPO, J.P. Morgan and Morgan Stanley Lead Offering
Quantinuum files a Form S‑1 to list on Nasdaq under QNT, with J.P. Morgan and Morgan Stanley as joint lead managers. Details on the offering and market impact.
Visual sourcing
No source-linked image is attached to this story yet. Measured Take avoids generic stock art when a relevant credited image is not available.
TL;DR
Quantinuum has filed a Form S‑1 to list Class A common stock on Nasdaq under ticker QNT, with J.P. Morgan and Morgan Stanley serving as joint lead book‑running managers.
Context Honeywell (NASDAQ: HON) announced the filing on behalf of its quantum‑computing subsidiary, Quantinuum. The filing moves the company from confidential drafts to a publicly available registration statement, a required step before any shares can be sold to investors. Nasdaq’s Global Select Market is the exchange’s top tier, reserved for companies meeting strict liquidity and governance standards.
Key Facts - Quantinuum filed a Form S‑1 with the U.S. Securities and Exchange Commission, signaling intent to conduct an initial public offering (IPO) of its Class A common stock. The shares will trade on Nasdaq under the ticker symbol QNT. - J.P. Morgan and Morgan Stanley are named joint lead book‑running managers. Jefferies and Evercore ISI will also act as book‑running managers, handling order taking and allocation. - The prospectus does not disclose the number of shares to be offered or the price range. Both variables will be set after the registration statement becomes effective and market conditions are assessed. - The offering remains subject to market conditions; there is no guarantee the IPO will close, nor certainty about timing, size, or pricing.
What It Means The public S‑1 filing marks a concrete step toward a standalone public market for Quantinuum, separating its valuation from Honeywell’s broader industrial portfolio. By choosing Nasdaq’s Global Select Market, Quantinuum aims to attract technology‑focused investors accustomed to high‑growth, high‑risk assets. The involvement of top-tier banks suggests confidence in the company’s ability to price the offering competitively once market sentiment is clearer.
Investors should monitor the SEC’s effectiveness notice, which will trigger the roadshow and pricing discussions. The eventual share count and price band will determine the IPO’s size and potential impact on Honeywell’s balance sheet, as Honeywell retains a significant stake in Quantinuum. Market participants will also watch comparable quantum‑technology listings for pricing benchmarks.
Looking Ahead The next milestone is the SEC’s declaration of effectiveness, followed by a pricing window that could reveal the valuation range for QNT. Stakeholders will gauge demand during the roadshow and assess how the IPO fits into broader trends in quantum computing investments.
Continue reading
More in this thread
Conversation
Reader notes
Loading comments...